Center of Lipidology provides consultations of experienced endocrinologists, cardiologists, nephrologists, gastroenterologists, dietologists, geneticists. Moreover, patients can receive psychological support: consultations, emotional crisis management, supportive therapy, relaxation techniques.
We provide services for these groups of diseases:
- Familial hypercholesterolemias
- Other rare hyperlipidemias
- Rare hypolipidemias
- Syndromic dyslipidemias
Research
Clinical pharmaceutical research in the Center of Lipidology:
- A Randomized, Double-Blind, Active-Controlled, Multicenter Study of Patients with Primary Hypercholesterolemia and High Cardiovascular Risk Who Are Not Adequately Controlled with Atorvastatin 10 mg: A Comparison of the Efficacy and Safety of Switching to Coadministration Ezetimibe and Atorvastatin Versus Doubling the Dose of Atorvastatin or Switching to Rosuvastatin.
- Phase 3 Multicenter, Double-Blind, Crossover Design Study to Evaluate Lipid-Altering Efficacy and Safety of 1 g/10 mg Extended-Release Niacin/Laropiprant/Simvastatin Combination Tablets in Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia
- Phase 3 Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Evaluation of The Efficacy, Safety, And Tolerability of Bococizumab (Pf-04950615), In Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome
Other biomedical research:
- International multicenter familial hypercholesterolemia monitoring study
- International multicenter study: Biomarkers for Inborn Errors of Metabolism (since 2020)
Last edited: 2021-12-22
